Concepedia

Hannah M. King

HM

Statistics

Publications

7

Citations

291

H-Index

7

Active since

2019

Affiliations

University of Nebraska Medical Center(Current)

Nebraska Medical Center

Hannah M. King is an author at University of Nebraska Medical Center specializing in medicine, drug discovery, and medicinal chemistry.

ORCID

Top concepts

Publications per year

2019–2022

7

Publications

7

Selective degradation of CDK6 by a palbociclib based PROTAC

Sandeep Rana, Mourad Bendjennat, Smit Kour et al. · Bioorganic & Medicinal Chemistry Letters · 2019 · 128 citations · Full text

, , +4

Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax

Hannah M. King, Sandeep Rana, Sydney P. Kubica et al. · Bioorganic & Medicinal Chemistry Letters · 2021 · 56 citations · Full text

, , +9

Synthesis and SAR studies of novel 1,2,4-oxadiazole-sulfonamide based compounds as potential anticancer agents for colorectal cancer therapy

Farheen Shamsi, Phool Hasan, Aarfa Queen et al. · Bioorganic Chemistry · 2020 · 50 citations

, , +9

CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax

Smit Kour, Sandeep Rana, Jacob I. Contreras et al. · Molecular Pharmacology · 2019 · 22 citations · Full text

HLA-B influences integrin beta-1 expression and pancreatic cancer cell migration

Bailee Sliker, Benjamin T. Goetz, Raina Barnes et al. · Experimental Cell Research · 2020 · 13 citations · Full text

, , +7

1–5 of 7